Title 21

PART 862 SUBPART D

Subpart D - Clinical Toxicology Test Systems

• 21 U.S.C. 351, 360, 360c, 360e, 360j, 360l, 371.
• 52 FR 16122, May 1, 1987, unless otherwise noted.

21:8.0.1.1.18.4.1.1	SECTION 862.3030	862.3030 Acetaminophen test system.
21:8.0.1.1.18.4.1.2	SECTION 862.3035	862.3035 Amikacin test system.
21:8.0.1.1.18.4.1.3	SECTION 862.3040	862.3040 Alcohol test system.
21:8.0.1.1.18.4.1.4	SECTION 862.3050	862.3050 Breath-alcohol test system.
21:8.0.1.1.18.4.1.5	SECTION 862.3080	862.3080 Breath nitric oxide test system.
21:8.0.1.1.18.4.1.6	SECTION 862.3100	862.3100 Amphetamine test system.
21:8.0.1.1.18.4.1.7	SECTION 862.3110	862.3110 Antimony test system.
21:8.0.1.1.18.4.1.8	SECTION 862.3120	862.3120 Arsenic test system.
21:8.0.1.1.18.4.1.9	SECTION 862.3150	862.3150 Barbiturate test system.
21:8.0.1.1.18.4.1.10	SECTION 862.3170	862.3170 Benzodiazepine test system.
21:8.0.1.1.18.4.1.11	SECTION 862.3200	862.3200 Clinical toxicology calibrator.
21:8.0.1.1.18.4.1.12	SECTION 862.3220	862.3220 Carbon monoxide test system.
21:8.0.1.1.18.4.1.13	SECTION 862.3240	862.3240 Cholinesterase test system.
21:8.0.1.1.18.4.1.14	SECTION 862.3250	862.3250 Cocaine and cocaine metabolite test system.
21:8.0.1.1.18.4.1.15	SECTION 862.3270	862.3270 Codeine test system.
21:8.0.1.1.18.4.1.16	SECTION 862.3280	862.3280 Clinical toxicology control material.
21:8.0.1.1.18.4.1.17	SECTION 862.3300	862.3300 Digitoxin test system.
21:8.0.1.1.18.4.1.18	SECTION 862.3320	862.3320 Digoxin test system.
21:8.0.1.1.18.4.1.19	SECTION 862.3350	862.3350 Diphenylhydantoin test system.
21:8.0.1.1.18.4.1.20	SECTION 862.3360	862.3360 Drug metabolizing enzyme genotyping system.
21:8.0.1.1.18.4.1.21	SECTION 862.3380	862.3380 Ethosuximide test system.
21:8.0.1.1.18.4.1.22	SECTION 862.3450	862.3450 Gentamicin test system.
21:8.0.1.1.18.4.1.23	SECTION 862.3520	862.3520 Kanamycin test system.
21:8.0.1.1.18.4.1.24	SECTION 862.3550	862.3550 Lead test system.
21:8.0.1.1.18.4.1.25	SECTION 862.3555	862.3555 Lidocaine test system.
21:8.0.1.1.18.4.1.26	SECTION 862.3560	862.3560 Lithium test system.
21:8.0.1.1.18.4.1.27	SECTION 862.3580	862.3580 Lysergic acid diethylamide (LSD) test system.
21:8.0.1.1.18.4.1.28	SECTION 862.3590	862.3590 Meprobamate test system.
21:8.0.1.1.18.4.1.29	SECTION 862.3600	862.3600 Mercury test system.
21:8.0.1.1.18.4.1.30	SECTION 862.3610	862.3610 Methamphetamine test system.
21:8.0.1.1.18.4.1.31	SECTION 862.3620	862.3620 Methadone test system.
21:8.0.1.1.18.4.1.32	SECTION 862.3630	862.3630 Methaqualone test system.
21:8.0.1.1.18.4.1.33	SECTION 862.3640	862.3640 Morphine test system.
21:8.0.1.1.18.4.1.34	SECTION 862.3645	862.3645 Neuroleptic drugs radioreceptor assay test system.
21:8.0.1.1.18.4.1.35	SECTION 862.3650	862.3650 Opiate test system.
21:8.0.1.1.18.4.1.36	SECTION 862.3652	862.3652 Organophosphate test system.
21:8.0.1.1.18.4.1.37	SECTION 862.3660	862.3660 Phenobarbital test system.
21:8.0.1.1.18.4.1.38	SECTION 862.3670	862.3670 Phenothiazine test system.
21:8.0.1.1.18.4.1.39	SECTION 862.3680	862.3680 Primidone test system.
21:8.0.1.1.18.4.1.40	SECTION 862.3700	862.3700 Propoxyphene test system.
21:8.0.1.1.18.4.1.41	SECTION 862.3750	862.3750 Quinine test system.
21:8.0.1.1.18.4.1.42	SECTION 862.3800	862.3800 Reagents for molecular diagnostic instrument test systems.
21:8.0.1.1.18.4.1.43	SECTION 862.3830	862.3830 Salicylate test system.
21:8.0.1.1.18.4.1.44	SECTION 862.3840	862.3840 Sirolimus test system.
21:8.0.1.1.18.4.1.45	SECTION 862.3850	862.3850 Sulfonamide test system.
21:8.0.1.1.18.4.1.46	SECTION 862.3870	862.3870 Cannabinoid test system.
21:8.0.1.1.18.4.1.47	SECTION 862.3880	862.3880 Theophylline test system.
21:8.0.1.1.18.4.1.48	SECTION 862.3900	862.3900 Tobramycin test system.
21:8.0.1.1.18.4.1.49	SECTION 862.3910	862.3910 Tricyclic antidepressant drugs test system.
21:8.0.1.1.18.4.1.50	SECTION 862.3950	862.3950 Vancomycin test system.

---